Alessandro Finkelsztejn

Alessandro Finkelsztejn

Auto-generated profile, based on publicly available information

Alessandro Finkelsztejn

Hospital de Clínicas de Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
YFYára Dadalti Fragoso
Yára Dadalti Fragoso
AFAlessandro Finkelsztejn
Alessandro Finkelsztejn
SGSidney Gomes
Sidney Gomes
DMDamacio Ramon Kaimen Maciel
Damacio Ramon Kaimen Maciel
COCelso Luis S. Oliveira
Celso Luis S. Oliveira
RCRafael A. Cristovam
Rafael A. Cristovam
OBJECTIVE: The increased prevalence of restless legs syndrome (RLS) in multiple sclerosis (MS) has recently been the subject of a few papers. The present study investigated the prevalence of RLS symptoms in MS patients and in controls in four Brazilian cities. Additionally, a systematic review and meta-analysis of the literature was carried out on the subject of RLS-MS. METHOD: MS patients and controls were investigated regarding the presence of the four typical symptoms of RLS. A questionnaire assessing RLS severity was also used for patients and controls presenting the four RLS symptoms criteria. The systematic review and meta-analysis on the subject were carried out according to the strict international criteria. RESULTS: In the present report, the RLS-MS association was confirmed as being more than fortuitous in Brazilian MS patients, in a multicenter case-control study. MS patients also presented RLS symptoms of greater severity than did the control population. A systematic review and meta-analysis of the literature showed that MS patients had a fourfold higher chance of presenting RLS than did the controls. CONCLUSION: Although underlying mechanisms to explain the association RLS-MS are still a matter of discussion, there is a clear association of these two neurological conditions.

1 June 2020 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
FFFernanda Mari Fagundes Fujihara
Fernanda Mari Fagundes Fujihara
PMPaulo Augusto de Arruda Mello
Paulo Augusto de Arruda Mello
RLRodrigo Leivas Lindenmeyer
Rodrigo Leivas Lindenmeyer
HPHelena Messinger Pakter
Helena Messinger Pakter
JLJaco Lavinsky
Jaco Lavinsky
FLFabio Lavinsky
Fabio Lavinsky
Purpose: To evaluate differences in the thickness of the individual macular layers between early, moderate, and severe glaucomatous eyes and compare them with healthy controls. Patients and Methods: Subjects with glaucoma presenting typical optic nerve head findings, high intraocular pressure with or without visual field (VF) damage and normal controls were included. All participants underwent 24– 2 perimetry and spectral-domain OCT. Patients were divided into three groups (early, moderate, and severe) based on the mean deviation of the VF and a healthy control group. The device segmented the layers automatically, and their measurements were plotted using the means of the sectors of the inner (3mm) and outer (6mm) circles of the ETDRS grid. Results: A total of 109 eyes qualified for the study: 14 in the control group and 52, 18 and 25 in the early, moderate and severe groups, respectively. Mean age was 66.13 (SD=12.38). The mean thickness of the circumpapillary retinal nerve fiber layer (RNFL), total macular thickness (TMT), macular RNFL, ganglion cell layer (GCL) and inner plexiform layer (IPL) were significantly different between the 4 groups, with progressive decrease in thickness. Significant overall difference was found for the inner nuclear layer (INL), and the severe glaucoma group presented thicker measurements than controls and early glaucoma. Outer nuclear layer (ONL) was thinner in severe glaucoma group compared with early glaucoma group. Conclusion: Individual macular layer measurement using the inner and outer circles of the ETDRS grid is useful to evaluate different stages of glaucoma. The INL thickening and ONL thinning in advanced glaucoma should be explored in the future studies.

7 February 2024 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MMMatheus Bernardon Morillos
Matheus Bernardon Morillos
WBWyllians Vendramini Borelli
Wyllians Vendramini Borelli
GNGiovani Noll
Giovani Noll
CPCristian Daniel Piccini
Cristian Daniel Piccini
MLMartim Bravo Leite
Martim Bravo Leite
CTCarolina Machado Torres
Carolina Machado Torres
Background Autoimmune encephalitis (AE) consists of a group of acquired diseases that affect the central nervous system. A myriad of phenotypes may be present at the onset. Due to the heterogeneity of clinical presentations, it is difficult to achieve uniformity for the diagnostic and therapeutic processes and follow-up strategies. Objective To describe a series of patients diagnosed with AE in a resource-limited public hospital in southern Brazil and to analyze therapeutics and outcomes. Methods We retrospectively reviewed the electronic medical records of patients diagnosed with AE at the Hospital de Clínicas de Porto Alegre from 2014 to 2022. Data collected included clinical presentation, neuroimaging, cerebrospinal fluid testings, electroencephalogram, autoantibodies, treatments, outcomes, follow-up time, degree of neurological impairment, and mortality. Results Data from 17 patients were retrieved. Eleven cases were classified as definite AE and 6 as possible AE. Autoantibodies were identified in 9 patients. Timing for diagnosis was impacted by the high costs associated with autoantibody testing. Most patients became functionally dependent (82.4%) and most survivors remained with autoimmune-associated epilepsy (75%). Five patients died during hospitalization, and one after a 26-month of follow-up. Conclusion In this resource-limited hospital, patients with AE had a worse clinical outcome than that previously described in the literature. Development of epilepsy during follow-up and mortality were greater, whilst functional outcome was inferior. Autoantibody testing was initially denied in most patients, which impacted the definitive diagnosis and the use of second-line therapies.

1 January 2025 in Radiologia Brasileira
Verified
Journal Article
Open access
VKViviana Regina Konzen
Viviana Regina Konzen
AFAlessandro Finkelsztejn
Alessandro Finkelsztejn
RSRaquel Prates dos Santos
Raquel Prates dos Santos
ASAdolfo Moraes de Souza
Adolfo Moraes de Souza
MRMatheus de Lima Ruffini
Matheus de Lima Ruffini
JDJuliana Ávila Duarte
Juliana Ávila Duarte
Objective: This study aimed to assess whether the evaluation of the central vein sign (CVS) and paramagnetic rim lesions (PRLs) using susceptibility-weighted magnetic resonance imaging (MRI) can distinguish multiple sclerosis (MS) from migraine. Materials and Methods: In this single-center observational study, we conducted a cross-sectional analysis of the CVS, determining the proportion of CVS-positive lesions per individual and absolute counts, using thresholds of 3 lesions (select3*) and 6 lesions (select6*), and of PRLs in participants with MS and in those with migraine, from 3.0-T MRI brain scans. Results: The study included 20 participants with MS, 20 with migraine, and 20 included as healthy controls. The proportion of participants with CVS-positive lesions was higher in the MS group than in the migraine group (61.8% vs. 10.4%), and PRLs were observed exclusively in the MS group. The presence of at least one PRL and the select6* criterion demonstrated the highest diagnostic accuracy within the study sample. Conclusion: The detection of the CVS and of a PRL on 3.0-T MRI scans may serve as a reliable biomarker to differentiate MS from migraine.

1 October 2021 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
FJFrancielle Fontana Jorge
Francielle Fontana Jorge
AFAlessandro Finkelsztejn
Alessandro Finkelsztejn
LRLuciano Palmeiro Rodrigues
Luciano Palmeiro Rodrigues
Background: Spasticity, fatigue, muscle weakness and changes in gait are some of the main motor symptoms of Multiple Sclerosis (MS). These changes can interfere with the patients’ quality of life. Objective: To characterize the motor and quality of life symptoms in patients with relapsing-remitting Multiple Sclerosis at a specialized center. Methods: Fifty five patients at the Neuroimmunology Outpatient Clinic of the Hospital de Clínicas de Porto Alegre were evaluated for fatigue (Fatigue Severity Scale — FSS), walking ability (Functional Ambulation Categories — FAC), impact of MS on walking (Multiple Sclerosis Walking Scale-12 — MSWS-12), walking speed (10-Meter Walk Test — 10MWT and the Times 25-foot Walk test — T25FW), functional independence (Barthel Index — BI), functional mobility (Timed Up and Go — TUG), and quality of life (Multiple Sclerosis Impact Scale — MSIS-29). Results: The patients were mostly women (69.1%), with average age of 43.3 (±12.1) years old, with time since diagnosis of 8.2 (±5.3) years, and EDSS average of 4.3 (±1.3). On the BI, the mean was 96.6 (±5.7) points and 80% of the patients had FAC 5. At MSIS-29, patients had a higher average score on the psychological scale (19.5±26.7) than on the physical scale (10.2±23.6). Most patients (69.1%) presented fatigue. Conclusion: The patients had preserved functional independence and functional walking ability and presence of fatigue. There was minimal impact of MS on patients’ quality of life.

1 January 2024 in Clinical and Biomedical Research
Verified
Journal Article
Open access
PDF file
GNGiovani Noll
Giovani Noll
TSTahiane de Brum Soares
Tahiane de Brum Soares
JDJuliana Avila Duarte
Juliana Avila Duarte
MMMatheus Bernardon Morillos
Matheus Bernardon Morillos
FSFernando Augusto Marion Spengler
Fernando Augusto Marion Spengler
JSJonas Alex Morales Saute
Jonas Alex Morales Saute
Introduction: Multiple sclerosis may rarely present alongside idiopathic thrombocytopenic purpura and scarcely ever following splenectomy for hematologic disease. Methods and Results: We report the case of a 51-year-old woman presenting with subacute onset of mild ataxia, dysarthria and lower limb dysesthesia in close temporal relationship with splenectomy performed as a treatment for steroid-dependent idiopathic thrombocytopenic purpura. MRI showed hyperintense T2/FLAIR multifocal white-matter lesions and there were highly positive cerebrospinal-fluid oligoclonal bands, picturing her first clinical episode of multiple sclerosis. She was treated with intravenous methylprednisolone, with significant improvement, and then started on multiple sclerosis disease-modifying therapy. Conclusion: This report suggests the possible role of splenectomy as an environmental trigger for clinical multiple sclerosis in genetically predisposed individuals, as well as for those with radiologically isolated syndrome. Introdução: A esclerose múltipla pode raramente apresentar-se em concomitância com a púrpura trombocitopênica idiopática e, excepcionalmente, após esplenectomia por doença hematológica. Métodos e Resultados: Relatamos o caso de uma mulher de 51 anos que apresentou início subagudo de ataxia leve, disartria e disestesia de membros inferiores em estreita relação temporal com esplenectomia realizada como tratamento para púrpura trombocitopênica idiopática cortico-dependente. A ressonância magnética mostrou lesões multifocais hiperintensas na substância branca em T2/FLAIR e foi evidenciada a presença de bandas oligoclonais exclusivas no líquor, caracterizando seu primeiro surto clínico de esclerose múltipla. Foi tratada com metilprednisolona intravenosa, com melhora significativa, e posteriormente submetida a terapia modificadora da doença para esclerose múltipla. Conclusão: Este relato de caso sugere o possível papel da esplenectomia como gatilho para o desencadeamento de esclerose múltipla clinicamente manifesta em indivíduos geneticamente predispostos, bem como para aqueles com síndrome radiologicamente isolada.